We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

Formulating Cannabinoid Particles for Therapeutics

|

Formulating Cannabinoid Particles for Therapeutics

Who's speaking at this Webinar?

Dr Natalia Sannikova
Research & Development Manager, Ascension Sciences
Tomas Skrinskas
Founder & CEO, Ascension Sciences
 

Recent literature increasingly supports the therapeutic use of cannabinoids in the development of novel medicines. Nanoparticles play a crucial role in increasing the solubility, stability, benefits and safety of cannabinoids as therapeutic agents. In this webinar, we review the challenges of cannabinoid-based drug development, and present the opportunities of nanotechnology in formulating cannabinoid nanoparticles.

During this webinar we will discuss:

  • Clinical Snapshot: History and challenges of cannabinoid-based drug development.
  • Technology Overview: Opportunities in nanotechnology and the microfluidic approach.
  • Characterization Methods: ELISA for dissolution studies.
  • Sample Preparation Challenges: Polymer nanoparticles, liposomes, emulsions on the HPLC.
  • Research Findings: The impact of lipid composition on liposome stability and cannabinoid drug encapsulation efficiency

Register Now
 

Stay connected with the latest news in cannabis extraction, science and testing

Get the latest news with the FREE weekly Analytical Cannabis newsletter

Comments
Advertisement